Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 34 | 35 | +1 |
| Shares | 9.42M | 8.43M | −988.9K (−10.5%) |
| Value | $74.5M | $52.1M | −$22.4M (−30.1%) |
New holders (5)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Eversept Partners, LP | 114,008 | $704.6K | 0.06% |
| Virtu Financial LLC | 18,610 | $115.0K | 0.01% |
| Mercer Global Advisors Inc | 16,726 | $103.0K | 0.00% |
| Envestnet Asset Management Inc | 16,726 | $103.0K | 0.00% |
| Jacobi Capital Management LLC | 3 | $0 | 0.00% |
Sold out (4)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Janus Henderson Group PLC | 245,095 | $1.93M |
| Tower Research Capital LLC (TRC) | 643 | $5.00K |
| Cubist Systematic Strategies, LLC | 600 | $5.00K |
| Panagora Asset Management Inc | 19 | $0 |